ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Valsrch
|
181 |
53K |
0 |
16:48 |
16:48 |
ASX - By Stock
|
181
|
53K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm completes oversubscribed Share Purchase Plan
|
|
Valsrch
|
9 |
2.1K |
0 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
9
|
2.1K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: First USA Patients Imaged with Technegas
|
|
Valsrch
|
14 |
4.0K |
1 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
14
|
4.0K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: CYC Results Summary
|
|
Valsrch
|
6 |
1.5K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
6
|
1.5K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Signs First USA Contract for Technegas
|
|
Valsrch
|
39 |
14K |
3 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
39
|
14K
|
3
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Signs First USA Contract for Technegas
|
|
Valsrch
|
39 |
14K |
4 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
39
|
14K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
Valsrch
|
64 |
17K |
4 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
64
|
17K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Receives USFDA Approval for Technegas
|
|
Valsrch
|
41 |
11K |
10 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
41
|
11K
|
10
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron achieves record monthly Travelan sales
|
|
Valsrch
|
33 |
7.8K |
3 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
33
|
7.8K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: FY2023 Full Year Results
|
|
Valsrch
|
52 |
16K |
4 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
52
|
16K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: FY2023 Full Year Results
|
|
Valsrch
|
52 |
16K |
3 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
52
|
16K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: FY2023 Full Year Results
|
|
Valsrch
|
52 |
16K |
2 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
52
|
16K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Confirms USFDA Scheduled Inspection Date
|
|
Valsrch
|
9 |
3.9K |
2 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
9
|
3.9K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron completes strategic investment in Ateria Health
|
|
Valsrch
|
26 |
7.0K |
7 |
26/11/22 |
26/11/22 |
ASX - By Stock
|
26
|
7.0K
|
7
|
|
ASX - By Stock
|
CYC |
Re:
Ann: CYC Board Changes
|
|
Valsrch
|
2 |
1.0K |
3 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
2
|
1.0K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
Valsrch
|
53 |
23K |
2 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
53
|
23K
|
2
|
|
ASX - By Stock
|
DNA |
Re:
Ann: Star Vegas Casino Operations to Resume
|
|
Valsrch
|
8 |
4.8K |
3 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
8
|
4.8K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical clinical trial results presented at ATS
|
|
Valsrch
|
64 |
31K |
2 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
64
|
31K
|
2
|
|
ASX - By Stock
|
CYC |
IV contrast shortage
|
|
Valsrch
|
1 |
607 |
1 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
1
|
607
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm USFDA Update
|
|
Valsrch
|
23 |
9.1K |
3 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
23
|
9.1K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Valsrch
|
2.5K |
1.1M |
1 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX purpose-built 4D lung scanner for its XV Technology
|
|
Valsrch
|
19 |
12K |
2 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
19
|
12K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Valsrch
|
2.5K |
1.1M |
1 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Valsrch
|
2.5K |
1.1M |
1 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
DNA |
Re:
Ann: Mega Bank Facility Repaid
|
|
Valsrch
|
13 |
5.1K |
3 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
13
|
5.1K
|
3
|
|
ASX - By Stock
|
DNA |
Re:
Ann: Mega Bank Facility Repaid
|
|
Valsrch
|
13 |
5.1K |
1 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
13
|
5.1K
|
1
|
|
ASX - By Stock
|
DNA |
Re:
Ann: Mega Bank Facility Repaid
|
|
Valsrch
|
13 |
5.1K |
3 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
13
|
5.1K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical presents at BP Healthcare Conference
|
|
Valsrch
|
93 |
21K |
0 |
20/11/21 |
20/11/21 |
ASX - By Stock
|
93
|
21K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical presents at BP Healthcare Conference
|
|
Valsrch
|
93 |
21K |
1 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
93
|
21K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Covid - 4DX
|
|
Valsrch
|
59 |
16K |
1 |
13/10/21 |
13/10/21 |
ASX - By Stock
|
59
|
16K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Covid - 4DX
|
|
Valsrch
|
59 |
16K |
1 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
59
|
16K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Covid - 4DX
|
|
Valsrch
|
59 |
16K |
0 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
59
|
16K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Covid - 4DX
|
|
Valsrch
|
59 |
16K |
0 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
59
|
16K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Covid - 4DX
|
|
Valsrch
|
59 |
16K |
4 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
59
|
16K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Covid - 4DX
|
|
Valsrch
|
59 |
16K |
3 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
59
|
16K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Covid - 4DX
|
|
Valsrch
|
59 |
16K |
3 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
59
|
16K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Just Out.
|
|
Valsrch
|
60 |
25K |
0 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
60
|
25K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Just Out.
|
|
Valsrch
|
60 |
25K |
2 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
60
|
25K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Market Update
|
|
Valsrch
|
199 |
67K |
0 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
199
|
67K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Market Update
|
|
Valsrch
|
199 |
67K |
5 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
199
|
67K
|
5
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Voluntary Suspension
|
|
Valsrch
|
157 |
51K |
6 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
157
|
51K
|
6
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Voluntary Suspension
|
|
Valsrch
|
157 |
51K |
1 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
157
|
51K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Navy medicine
|
|
Valsrch
|
3 |
1.4K |
3 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
3
|
1.4K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: IMM124E May Offer New Modality for Inhibition of SARS-CoV-2
|
|
Valsrch
|
51 |
11K |
4 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
51
|
11K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Half Yearly Report and Accounts
|
|
Valsrch
|
60 |
16K |
3 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
60
|
16K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
2021 lookout
|
|
Valsrch
|
185 |
50K |
1 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
185
|
50K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
2021 lookout
|
|
Valsrch
|
185 |
50K |
3 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
185
|
50K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
2021 lookout
|
|
Valsrch
|
185 |
50K |
2 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
185
|
50K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
2021 lookout
|
|
Valsrch
|
185 |
50K |
2 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
185
|
50K
|
2
|
|
ASX - By Stock
|
DNA |
Re:
Ann: 1H FY21 Results Investor Briefing Q&A
|
|
Valsrch
|
38 |
10K |
0 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
38
|
10K
|
0
|
|